Effective Utilization Management Programs for Specialty Pharmacies

Specialty pharmacies can minimize "cost to treat" by identifying which specialty drugs have dose optimization opportunities, noted Michael Einodshofer, RPh, MBA, director of utilization management, Walgreens, at the 2013 PBMI Drug Benefit Conference.

Specialty pharmacies can minimize "cost to treat" by identifying which specialty drugs have dose optimization opportunities, noted Michael Einodshofer, RPh, MBA, director of utilization management, Walgreens, at the 2013 PBMI Drug Benefit Conference.

For more videos featuring Michael Einodshofer, click on our Multimedia page.

Related Videos
View All
Related Content

New Biomarker May Indicate Success of CAR T-cell Response in Lymphoma Patients

January 26th 2023

Pharmacy Focus: Psychedelic Pharmacy - Understanding Natural vs. Synthetic Psychedelics

January 13th 2023

Telemedicine Associated With Direct, Indirect Cost Savings for Patients With Cancer

January 24th 2023

Pharmacy Focus: Public Health Matters- Celebrating American Pharmacist Month Part 2 with Autumn Zuckerman

October 13th 2022

FDA Grants Rare Pediatric Disease Designation to OR-440 for Treatment of Adrenocortical Carcinoma

January 23rd 2023

Study: Black, Hispanic Individuals With Epilepsy Are Less Likely to be Prescribed Newer Drugs

January 20th 2023

New Biomarker May Indicate Success of CAR T-cell Response in Lymphoma Patients

January 26th 2023

Pharmacy Focus: Psychedelic Pharmacy - Understanding Natural vs. Synthetic Psychedelics

January 13th 2023

Telemedicine Associated With Direct, Indirect Cost Savings for Patients With Cancer

January 24th 2023

Pharmacy Focus: Public Health Matters- Celebrating American Pharmacist Month Part 2 with Autumn Zuckerman

October 13th 2022

FDA Grants Rare Pediatric Disease Designation to OR-440 for Treatment of Adrenocortical Carcinoma

January 23rd 2023

Study: Black, Hispanic Individuals With Epilepsy Are Less Likely to be Prescribed Newer Drugs

January 20th 2023

New Biomarker May Indicate Success of CAR T-cell Response in Lymphoma Patients

January 26th 2023

Pharmacy Focus: Psychedelic Pharmacy - Understanding Natural vs. Synthetic Psychedelics

January 13th 2023

Telemedicine Associated With Direct, Indirect Cost Savings for Patients With Cancer

January 24th 2023

Pharmacy Focus: Public Health Matters- Celebrating American Pharmacist Month Part 2 with Autumn Zuckerman

October 13th 2022

FDA Grants Rare Pediatric Disease Designation to OR-440 for Treatment of Adrenocortical Carcinoma

January 23rd 2023

Study: Black, Hispanic Individuals With Epilepsy Are Less Likely to be Prescribed Newer Drugs

January 20th 2023
About Us
Advertise
Contact Us
Editorial Staff
Privacy Policy
Terms & Conditions
Do Not Sell My Information
Contact Info

2 Clarke Drive
Cranbury, NJ 08512

609-716-7777

© 2023 MJH Life Sciences

All rights reserved.